Christian Waldherr

Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.

Christian Waldherr, Miklos Pless, Helmut R. Maëcke et al. · PubMed · 2002 · 446 citations

The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: A clinical phase II study

Christian Waldherr, Misha Pless, Helmut R. Maëcke et al. · Annals of Oncology · 2001 · 394 citations

Neuroendocrine Tumours, Medicine, Pharmacology +7

MR Imaging of Parotid Tumors: Typical Lesion Characteristics in MR Imaging Improve Discrimination between Benign and Malignant Disease

Andreas Christe, Christian Waldherr, Richard L. Hallett et al. · American Journal of Neuroradiology · 2011 · 242 citations · Full text

Synthesis and Evaluation of Bombesin Derivatives on the Basis of Pan-Bombesin Peptides Labeled with Indium-111, Lutetium-177, and Yttrium-90 for Targeting Bombesin Receptor-Expressing Tumors

Hanwen Zhang, Jianhua Chen, Christian Waldherr et al. · Cancer Research · 2004 · 197 citations

Medicinal Chemistry, Drug Target, Pan-bombesin Peptides +15

Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability.

Benjamin S. Halpern, Magnus Dahlbom, Andrew Quon et al. · PubMed · 2004 · 143 citations